Finance

Lists
Why is BMHS down 3.16%?
Dive Deeper
BMHS:IDX
Bundamedik Tbk PT
IDR 184.00
-3.16%
(-6.00) 1D
Nov 9, 4:09:51 PM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for BMHS...
Open
IDR 190
High
IDR 190
Low
IDR 180
Mkt. cap
1.58T
Avg. vol.
850.81K
Volume
1.95M
Dividend
0.56%
Quarterly dividend
IDR 0
Ex-dividend date
Jun 10, 2024
P/E ratio
314.61
52-wk high
IDR 246
52-wk low
IDR 150
EPS
IDR 1
Shares outstanding
8.60B
No. of employees
2K
Open
IDR 190
High
IDR 190
Low
IDR 180
Mkt. cap
1.58T
Avg. vol.
850.81K
Volume
1.95M
Dividend
0.56%
Quarterly dividend
IDR 0
Ex-dividend date
Jun 10, 2024
P/E ratio
314.61
52-wk high
IDR 246
52-wk low
IDR 150
EPS
IDR 1
Shares outstanding
8.60B
No. of employees
2K
News stories
From web sources and news partners
About Bundamedik Tbk PT
CEO-
Employees1.86K
Founded1961
Headquarters-
SectorHealth Care
IndustryHealth care provider
Websitebmhs.co.id
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
459.45B
371.09B
396.45B
419.66B
Cost of goods sold
257.96B
204.95B
218.82B
228.05B
Cost of revenue
257.96B
204.95B
218.82B
228.05B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
152.06B
148.52B
161.16B
167.69B
Operating expense
173.28B
152.70B
160.38B
180.03B
Total operating expenses
431.24B
357.65B
379.20B
408.08B
Operating income
28.21B
13.45B
17.25B
11.58B
Other non operating income
2.11B
-1.81B
-1.90B
-1.99B
EBT including unusual items
19.15B
143.96M
-24.15B
25.37B
EBT excluding unusual items
18.94B
143.96M
3.78B
-2.56B
Income tax expense
9.49B
36.62M
-2.72B
3.00B
Effective tax rate
49.53%
25.43%
11.26%
11.81%
Other operating expenses
21.21B
4.17B
-772.82M
12.34B
Net income
170.33M
65.72M
-9.67B
14.27B
Net profit margin
0.04%
0.02%
-2.44%
3.40%
Earnings per share
-
-
-
-
Interest and investment income
7.77B
4.51B
4.22B
3.40B
Interest expense
-19.15B
-16.00B
-15.78B
-15.55B
Net interest expenses
-11.38B
-11.50B
-11.57B
-12.15B
Depreciation and amortization charges
-
-
-
-
EBITDA
37.74B
33.82B
37.53B
38.08B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps